← Eichor
Condition: Cns Sarcoma Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Cns Sarcoma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Superiority Trial Evaluating Digitalized Information Media for Patients With Advanced Sarcomas Receiving Systemic Treatm
NA · 11 location(s) · Centre Oscar Lambret · NCT06211257Study of CAR T-Cells Targeting the GD2 With IL-15+iCaspase9 for Relapsed/Refractory Neuroblastoma or Relapsed/Refractory
Phase 1 · 2 location(s) · UNC Lineberger Comprehensive Cancer Center · NCT03721068At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer
Phase 2 · 2 location(s) · Mayo Clinic · NCT05969860Intravital Microscopy in Human Solid Tumors
NA · 1 location(s) · Mayo Clinic · NCT03823144Clinical Orthopaedic Data Bank (Acute and Chronic)
Phase N/A · 1 location(s) · University of Florida · NCT00411060International Rare Brain Tumor Registry
Phase N/A · 10 location(s) · Children's National Research Institute · NCT05697874A Study of Circulating Tumor DNA (ctDNA) Testing for People With B-Cell Lymphoma
Phase 2 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT06736613Q702 for the Treatment of Patients With Hematologic Malignancies
Phase 1 · 2 location(s) · Mayo Clinic · NCT06712810International PPB/DICER1 Registry
Phase N/A · 1 location(s) · Children's Hospitals and Clinics of Minnesota · NCT03382158PROMIS and Mobility Evaluation in Sarcoma Patients
Phase N/A · 4 location(s) · University of Calgary · NCT07227961Pediatric Radiation Therapy Registry
Phase N/A · 2 location(s) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · NCT07129317Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
Phase 1/Phase 2 · 12 location(s) · Milton S. Hershey Medical Center · NCT06465199Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric P
Phase 1 · 5 location(s) · ITM Solucin GmbH · NCT06441331Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Phase N/A · 2 location(s) · Sanford Health · NCT01793168Targeted Oligometastatic Radiation in Pediatric and Young Adult Patients With Soft Tissue and Bone Sarcoma
NA · 3 location(s) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · NCT06796543Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimer
Phase 1 · 1 location(s) · Seattle Children's Hospital · NCT07148050Biobank and Register of Patients With Agresive Tumors for Translational and Analytical Research
Phase N/A · 1 location(s) · N.N. Petrov National Medical Research Center of Oncology · NCT05539677Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
Phase 2 · 1 location(s) · University of California, Irvine · NCT06580002Engineering Immune Organoids to Study Pediatric Cancer
NA · 2 location(s) · Gustave Roussy, Cancer Campus, Grand Paris · NCT05890781Integrated Cancer Repository for Cancer Research
Phase N/A · 42 location(s) · University of Nebraska · NCT02012699Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treat
Phase 1/Phase 2 · 1 location(s) · Fundación de investigación HM · NCT06607692cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Phase N/A · 17 location(s) · Adela, Inc · NCT05366881A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
Phase 1/Phase 2 · 68 location(s) · Turning Point Therapeutics, Inc. · NCT04094610Vorinostat in Combination With Chemotherapy in Relapsed/Refractory Solid Tumors and CNS Malignancies
Phase 1 · 1 location(s) · New York Medical College · NCT04308330Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials
NA · 347 location(s) · Eastern Cooperative Oncology Group · NCT05108298Avapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Solid Tumors
Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT04771520
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.